News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BOJ's Kuroda urged gradual interest-rate increases and tighter fiscal settings, warning expansionary government measures could raise inflation and bond yields.
  • Taiwan's stock index hit a record high, led by glass, plastic and optoelectronics, while commodities and the TWD strengthened.
  • Grupo Aeroportuario del Sureste reported Q4 EBITDA fell about 5% to MXN4.9bn, with margins down as costs rose and aeronautical revenue weakened.
  • VeriSign trades near its 52-week support, with oversold technicals and steady cash flow cited as a favorable swing-trade setup.
  • Palantir has retraced ~35% from its high and is pitched as a tactical buy with an entry, stop, and mid-term target amid oversold signals.

Latest Articles

KeyBanc Sticks With Overweight on Revvity, Cites Buybacks and Q4 Momentum

KeyBanc Sticks With Overweight on Revvity, Cites Buybacks and Q4 Momentum

KeyBanc has reaffirmed an Overweight rating on Revvity Inc (NYSE: RVTY) and set a $125 price target, signaling roughly 16.7% upside from the current share price. The firm maintained its positive view even after Revvity guided fiscal 2026 organic growth of 2-3%, noting stronger end-of-year momentum and opportunities from accelerated share buybacks.

Relay Therapeutics Shares Rise After FDA Grants Breakthrough Therapy Status for Zovegalisib-Fulvestrant Regimen

Relay Therapeutics Shares Rise After FDA Grants Breakthrough Therapy Status for Zovegalisib-Fulvestrant Regimen

Relay Therapeutics Inc. (NASDAQ: RLAY) saw its stock climb in premarket trading after the U.S. Food and Drug Administration awarded Breakthrough Therapy designation to zovegalisib in combination with fulvestrant for a defined breast cancer population. The decision was supported by Phase 1/2 ReDiscover trial data and covers adults with PIK3CA-mutant…

What Broadcom Must Prove to Regain Momentum, According to Morgan Stanley

What Broadcom Must Prove to Regain Momentum, According to Morgan Stanley

Morgan Stanley says Broadcom’s recent underperformance could reverse if the company clears key questions about competitive dynamics, profitability from rack sales and overall valuation. Analyst Joseph Moore highlights concerns around TPU competition, customer-owned ASIC tooling and margins tied to Anthropic rack deployments, but judges many worries…

Sangoma (SANG) - Cheap Name, Underappreciated Margin Inflection

Sangoma (SANG) - Cheap Name, Underappreciated Margin Inflection

Sangoma is a small-cap Communications-as-a-Service provider trading at $4.99 with a market cap of roughly $158M and a sub-1.0 P/B. Recent operating dynamics point to a likely margin inflection from higher-margin trunking and platform revenue that the market is not fully pricing. This idea is a tactical long for a mid-term horizon (45 trading days) …

Buy the CapEx Dip: Oracle's $50B Bet on OCI Could Reset Growth

Buy the CapEx Dip: Oracle's $50B Bet on OCI Could Reset Growth

Oracle's plan to raise $45-50 billion to fund AI-focused cloud expansion has pushed the stock lower but also creates a high-conviction trade: buy into the sell-off at $160 with a long-term horizon. Technicals show oversold conditions, fundamentals show a profitable software base and strong ROE, and analysts still forecast upside. The trade accepts …

Exxon Mobil: Buy the Dip — Quality Cash Flow at a Fair Price

Exxon Mobil: Buy the Dip — Quality Cash Flow at a Fair Price

Exxon Mobil is trading near $138 while delivering industry-leading production and cash flow. With a market cap around $580B, EV/EBITDA near 9.2 and roughly $24B in free cash flow, the company offers a mix of yield, buybacks and operational optionality that buffers it against cyclical oil weakness. This trade idea lays out entry, stops and targets f…

U.S. Probes Crypto Links to Iran as On-Chain Activity Surges

U.S. Probes Crypto Links to Iran as On-Chain Activity Surges

U.S. authorities are assessing whether certain cryptocurrency platforms have been used to help Iranian state-linked actors and others evade sanctions, as blockchain firms record a surge in crypto flows connected to Iran. Estimates from multiple analytics firms point to billions of dollars in on-chain activity in recent years, with disagreement over…

Barkin: Fed’s Rate Cuts Have Bolstered Jobs While Inflation Nears Final Stretch

Barkin: Fed’s Rate Cuts Have Bolstered Jobs While Inflation Nears Final Stretch

Richmond Federal Reserve President Tom Barkin said the rate cuts enacted since fall 2024 have provided insurance for the labor market as the Fed works to finish the ‘last mile’ of returning inflation to its 2% goal. Barkin noted that unemployment remains low by historical measures and inflation is about one percentage point above target but is expe…

Fed Governor Miran Urges More Than a Point of Rate Cuts This Year

Fed Governor Miran Urges More Than a Point of Rate Cuts This Year

Federal Reserve Governor Stephen Miran told Fox Business Network he expects more than a percentage point of interest rate reductions this year, arguing current policy is too restrictive even though headline inflation remains above the 2% target. Miran, whose term technically ended at the close of January but who remains in office until a successor …

Apple: Capital-Light AI Features Spark an iPhone Supercycle Trade

Apple: Capital-Light AI Features Spark an iPhone Supercycle Trade

Apple's newest window of upside is less about heavy new factories and more about software-led AI features that accelerate iPhone replacement and lift services monetization. The company prints massive free cash flow and runs a disciplined capital plan; combine that with early signs of a 23% iPhone sales surge and constructive technicals and you have…

GLJ Research Lowers Daqo New Energy to Sell, Sets $18.13 Target

GLJ Research Lowers Daqo New Energy to Sell, Sets $18.13 Target

GLJ Research cut its rating on Daqo New Energy (NYSE: DQ) from Buy to Sell and assigned a new price target of $18.13, reflecting a material downside from recent levels. The downgrade cites uncertainty in China’s polysilicon supply-and-demand balance and regulatory execution, while company-level metrics show a projected revenue decline and deeply ne…

TSX Futures Climb as Gold Steadies and Earnings Flood Looms

TSX Futures Climb as Gold Steadies and Earnings Flood Looms

Futures tied to Canada’s main stock index moved higher as gold prices stabilized after steep losses and traders prepared for a large slate of corporate results. Strength in consumer sectors supported the TSX rebound, while the energy group remained pressured by softer oil following signs of easing U.S.-Iran tensions. U.S. futures also ticked up ami…

Stephens Flags Consumer Names Poised to Outperform in 2026 Best Ideas Report

Stephens Flags Consumer Names Poised to Outperform in 2026 Best Ideas Report

Stephens Research’s 2026 Best Ideas list highlights a selection of consumer-focused companies the firm expects to outperform peers next year. The brokerage emphasizes that durable brands, the ability to raise prices and idiosyncratic operational improvements - rather than broad macro trends - underpin the call. Top picks span specialty retail, cons…